To CANCER IMMUNITY Home Page

Figure 1

NY-ESO-1b-specific immune response of baseline seronegative patients (cohort 2) at various time points. Bars show the number of spots per 25000 CD8+ cells in an ELISPOT assay after 6 days of prestimulation. *Indicates patients who had previously been vaccinated in the LUD 00-014 study.

 

Copyright © 2007 by Elke Jäger